E

Eric van der Putten

Partner
💼 Partner at Aglaia →
About

Eric van der Putten is a Partner at Aglaia Oncology Funds. Aglaia invests in oncology drug development companies, focusing on early-stage breakthrough inventions with the potential to transform cancer treatment. The Aglaia team has decades of experience in cancer research and oncology drug development and has built a reputation in starting up biotech companies focused on oncology drug development since 2004. Aglaia defines the strategic directions of its portfolio companies in collaboration with innovators and entrepreneurs, bringing hands-on experience in designing research and development plans, from early screening and animal feasibility studies through clinical studies. Aglaia has invested in 12 early stage companies, of which 6 were founded by Aglaia, and the team has been involved in the development of more than 100 oncology products.

Focus Areas

BioTech, Oncology

Verified Contact & Outreach Agent

Direct Professional Email Pattern

[email protected] | [email protected]

AI Outreach Agent Pitch Writer

Compose an personalized, high-converting outreach message targeting their exact investment interest...

Unlock Direct Partner Outreach

View verified contact information and use our active Outreach Composer agent to draft custom intro pitches in seconds.

Connect via GRID to Outreach

100% free account · Get started in 1-click